tradingkey.logo

Inspire Veterinary Partners Inc

IVP

0.717USD

-0.063-8.12%
Horarios del mercado ETCotizaciones retrasadas 15 min
3.69MCap. mercado
PérdidaP/E TTM

Inspire Veterinary Partners Inc

0.717

-0.063-8.12%
Más Datos de Inspire Veterinary Partners Inc Compañía
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. It specializes in small animal general practice hospitals which serve all manner of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and various other health and wellness offerings.
Información de la empresa
Símbolo de cotizaciónIVP
Nombre de la empresaInspire Veterinary Partners Inc
Fecha de salida a bolsaAug 30, 2023
Director ejecutivoMr. Kimball Carr
Número de empleados113
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 30
Dirección780 Lynnhaven Pkwy #400
CiudadVIRGINIA BEACH
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal23452
Teléfono17572883088
Sitio Webhttps://www.inspirevet.com/
Símbolo de cotizaciónIVP
Fecha de salida a bolsaAug 30, 2023
Director ejecutivoMr. Kimball Carr
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Lynley Kees
Ms. Lynley Kees
Vice President of Human Resources
Vice President of Human Resources
--
--
Mr. Kevin M. Mcgrath
Mr. Kevin M. Mcgrath
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
-100.00%
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--
Mr. Larry Alexander
Mr. Larry Alexander
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Lynley Kees
Ms. Lynley Kees
Vice President of Human Resources
Vice President of Human Resources
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Armistice Capital LLC
9.57%
UBS Financial Services, Inc.
0.56%
Geode Capital Management, L.L.C.
0.47%
Tower Research Capital LLC
0.10%
Other
89.29%
Accionistas
Accionistas
Proporción
Armistice Capital LLC
9.57%
UBS Financial Services, Inc.
0.56%
Geode Capital Management, L.L.C.
0.47%
Tower Research Capital LLC
0.10%
Other
89.29%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
9.67%
Investment Advisor
0.57%
Investment Advisor/Hedge Fund
0.48%
Other
89.28%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
36
227.34K
10.73%
+188.01K
2025Q1
37
233.23K
11.15%
+199.50K
2024Q4
35
26.63K
1.96%
+14.11K
2024Q3
29
12.19K
10.24%
+9.83K
2024Q2
26
1.53K
5.46%
+829.00
2024Q1
24
680.00
3.62%
+167.00
2023Q4
22
514.00
27.03%
+264.00
2023Q3
15
280.00
16.84%
+280.00
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Armistice Capital LLC
202.90K
9.57%
+202.90K
--
Mar 31, 2025
UBS Financial Services, Inc.
11.95K
0.56%
+11.38K
+1989.16%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.04K
0.47%
+2.11K
+26.57%
Mar 31, 2025
Tower Research Capital LLC
2.17K
0.1%
+1.52K
+233.74%
Mar 31, 2025
Osaic Holdings, Inc.
160.00
0.01%
+36.00
+29.03%
Mar 31, 2025
Harbour Investments, Inc
54.00
0%
--
--
Mar 31, 2025
MAI Capital Management, LLC
39.00
0%
--
--
Mar 31, 2025
Keiser (Charles Stith)
10.00
0%
--
--
May 13, 2025
BofA Global Research (US)
11.00
0%
+2.00
+22.22%
Mar 31, 2025
Wells Fargo Advisors
4.00
0%
+4.00
--
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
Fecha
Tipo
Relación
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Jan 23, 2025
Merger
25<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
Apr 17, 2024
Merger
100<1
KeyAI